Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
about
Cancer cachexia--pathophysiology and managementC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewBody mass index and colorectal cancer prognosis: a systematic review and meta-analysis.A systems biology approach to invasive behavior: comparing cancer metastasis and suburban sprawl developmentPredictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma.Cytokines and cancer anorexia cachexia syndrome.Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapyThe relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.Cancer cachexia: mechanisms and clinical implications.Nutritional status and quality of life of the gastric cancer patients in Changle County of ChinaThe relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancerResearch methodology: cancer cachexia syndrome.The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer.Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical NephrectomyA systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying.Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer.The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder.The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer.Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer.Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas.A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer.The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancerComparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancerEvaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastasesThe systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer.Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapyNon-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19Animal models of the cancer anorexia-cachexia syndrome.C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians.Weight changes correlate with alterations in subjective physical function in advanced cancer patients referred to a specialized nutrition and rehabilitation team.
P2860
Q24605567-6BACD00B-0D2A-4C09-B68A-B41BEB191BD6Q26771557-0E7245B3-4639-49D7-A951-34EEF09A3EB9Q30249342-306467E4-AD87-4AB3-B6E6-0995AD7871A9Q33533975-EBC7253D-02E9-493A-8986-895ECB73C187Q33684941-42B57F30-5186-46B8-BF98-41567FF0529DQ34011011-353F0554-20D1-4081-B0DE-29739C3D5DD2Q34079559-D20647B0-2284-4C68-8451-7586515435CBQ34241072-CC15E43D-7DAD-42E7-96F2-6166D8C19AF5Q34369105-CA173B0F-4139-4E24-8BBB-CD09FBF2ADF6Q34631019-71636033-F0C6-4304-9941-15CEAE55FD4EQ35011337-0CD14079-B33C-4061-9226-6DE600A215C5Q35551037-F5CD06B0-BC80-4657-BB31-A9C17CFED387Q35872798-DF7136C3-2057-4D44-BB70-87C2604977DAQ35954348-B7044A04-BD83-485C-A1CB-CB76AB0FAC3DQ36148206-537244E5-9C1E-4BD5-8C4C-B0B4FD7DF561Q36338248-6A926D02-F0B2-4521-B5AC-7E5338716E84Q36610116-7E2B4115-CED4-4DE7-9F1F-260CE3CEB1FFQ36611805-0A22A981-4CDD-4E3C-BC49-7BD6AA7EF18BQ36612383-F5AE595D-B157-42E9-976A-6BA6DEDC2A7BQ36613615-F3FA2F79-5F10-4FDE-99B4-44FCF2D73D33Q36613902-5DFD6277-1472-47C5-A8B8-DAAFD8CF3E57Q36614306-F0528DF3-C045-4E96-80BE-312FE3B80A08Q36614384-B9EE5EAB-0F2A-4463-8B25-FC0975991DC8Q36615780-9CC1F235-06E3-4431-88F7-DB75B9B6A41BQ36615878-54059E34-217A-4301-972D-9391DC2CC827Q36616232-5BC592E2-4B73-4AA9-BF7A-39A086D74915Q36616245-03C9CAB3-FEA1-439E-8161-ECD9A2BEAA67Q36623998-A1AC6D83-C6DD-4290-A7FF-639064E7C7F7Q36648454-6F67C1FA-E3A9-41A4-93BC-899573859768Q36695064-F3AD65DB-26AE-4518-BD53-333B56CE472BQ36695128-C3F36B71-F6A6-48A2-982C-1A3EAC5903CCQ36695381-B5FDE969-883A-4AC3-82C6-7187834A3E6EQ36695683-CD1AD3DD-2703-4243-BF00-4AC319A67CBEQ37030118-A0A8F9F1-31C3-4ED7-92D4-32A22B7B1D8BQ37152934-D8A9AF2A-7FC7-41C6-B618-37222195B15AQ37161846-78A55499-713A-4366-8D93-288483E2F243Q37667893-756CAF88-241F-473C-A37E-F0D690A4B60AQ37780478-39287A1B-C0EB-4F1B-A512-563503C14A15Q37835621-F4714247-1A88-4A8E-A4EB-A698A199EB79Q38084604-F371D803-4E98-4956-8997-2E99B62DB186
P2860
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
@en
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
@nl
type
label
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
@en
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
@nl
prefLabel
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
@en
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
@nl
P2093
P1433
P1476
Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
@en
P2093
McArdle CS
McMillan DC
O'Gorman P
P356
10.1207/S15327914NC3701_4
P577
2000-01-01T00:00:00Z